2-propanol has been researched along with moxifloxacin in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 10 (62.50) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bouffioux, C; Caspers, L; Deflorenne, C; Janssens, X; Koch, P; Willermain, F | 1 |
| Broens, A; Collignon, N | 1 |
| Augustinus, A; Hondeghem, K; Kreps, EO; Leroy, BP; Schauwvlieghe, PP; Sys, C; Van de Veire, S | 1 |
| Fanlo, P; Heras-Mulero, H; Plaza-Ramos, P; Zubicoa, A | 1 |
| Font Juliá, E; Hernández Pardines, F; Molina Martin, JC; Serra Verdú, MC | 1 |
| Klonner, J; Salchow, D | 1 |
| Ansari, Y; Capewell, N; Hui, BTK; Liu, X | 1 |
| Camós-Carreras, A; Eixarch, A; Sánchez-Dalmau, B; Sánchez-Vela, L | 1 |
| Bakbak, B; Gonul, S | 1 |
| Compains Silva, E; Echeverria-Palacios, M; Mozo Cuadrado, M; Zubicoa, A | 1 |
| Arteaga-Rivera, K; de-la-Torre, A; Neira-Segura, N; Reyes-Guanes, J; Rivera-Valdivia, N | 1 |
| Liaboe, C; Samuelson, TW | 1 |
| Arunkumar, WV; Lagvankar, M; Patnaik, G | 1 |
| Gürelik, G; Özdek, Ş; Özdemir, HB; Yüksel, M | 1 |
| Lončarić, K; Radmilović, M; Tadić, R; Vatavuk, Z | 1 |
16 other study(ies) available for 2-propanol and moxifloxacin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin.
Topics: Adult; Anti-Infective Agents; Aza Compounds; Eye Diseases; Fluoroquinolones; Humans; Intraocular Pressure; Iris; Laser Coagulation; Male; Moxifloxacin; Pigmentation Disorders; Quinolines; Transillumination; Treatment Outcome; Uveitis, Anterior | 2010 |
[Moxiflaxin and iris transillumination].
Topics: Acute Disease; Adult; Bronchitis; Female; Fluoroquinolones; Humans; Iris; Iris Diseases; Moxifloxacin; Pigment Epithelium of Eye | 2016 |
Is oral moxifloxacin associated with bilateral acute iris transillumination?
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Female; Fluoroquinolones; Humans; Iris; Iris Diseases; Male; Middle Aged; Moxifloxacin | 2018 |
Bilateral acute iris transillumination syndrome. A case report.
Topics: Acute Disease; Anti-Bacterial Agents; Diagnostic Errors; Female; Glaucoma, Open-Angle; Humans; Iris; Middle Aged; Moxifloxacin; Mydriasis; Respiratory Tract Infections; Syndrome; Uveitis, Anterior | 2018 |
Aqueous humor misdirection syndrome after glaucoma filtering surgery in patient with bilateral acute iris transillumination (BAIT) syndrome.
Topics: Anti-Inflammatory Agents; Aqueous Humor; Atrophy; Combined Modality Therapy; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Iridectomy; Iris; Laser Therapy; Middle Aged; Moxifloxacin; Mydriasis; Phacoemulsification; Postoperative Complications; Prednisone; Syndrome; Trabeculectomy; Vitrectomy | 2018 |
[Unusual anisocoria].
Topics: Anisocoria; Female; Glaucoma, Open-Angle; Humans; Iris; Iris Diseases; Middle Aged; Moxifloxacin | 2021 |
Bilateral acute anterior uveitis and iris atrophy caused by moxifloxacin.
Topics: Acute Disease; Anti-Bacterial Agents; Atrophy; Humans; Iris; Male; Middle Aged; Moxifloxacin; Mydriasis; Pneumonia; Tomography, Optical Coherence; Treatment Outcome; Uveitis, Anterior | 2020 |
Bilateral acute iris transillumination induced by moxifloxacin.
Topics: Humans; Iris; Iris Diseases; Moxifloxacin; Transillumination | 2021 |
Anterior Uveitis Due to Intracameral Moxifloxacin: A Case Report.
Topics: Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Iris Diseases; Moxifloxacin; Uveitis, Anterior | 2022 |
Unilateral acute iris transillumination like syndrome following intracameral moxifloxacin injection.
Topics: Anti-Bacterial Agents; Humans; Iris; Male; Middle Aged; Moxifloxacin; Syndrome; Transillumination | 2022 |
Severe sequelae in bilateral acute iris transillumination syndrome secondary to the use of oral moxifloxacin: a case report.
Topics: Female; Fluoroquinolones; Humans; Iris; Iris Diseases; Middle Aged; Moxifloxacin; Transillumination | 2021 |
Acute iris toxicity following bilateral gel stent implantation with mitomycin-C and intracameral moxifloxacin January consultation #1.
Topics: Aged; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Mitomycin; Moxifloxacin; Referral and Consultation; Stents | 2022 |
Bilateral Acute Depigmentation of Iris (BADI) Post COVID Infection following Systemic Moxifloxacin Therapy.
Topics: Adult; Aged; COVID-19; Female; Humans; Iris; Iris Diseases; Moxifloxacin; RNA, Viral; SARS-CoV-2 | 2023 |
Bilateral acute Iris transillumination after COVID-19 pneumonia.
Topics: Aged; COVID-19; Humans; Iris; Iris Diseases; Male; Moxifloxacin; Transillumination | 2023 |
Bilateral Acute Iris Transillumination (BAIT): A Rare Syndrome Possibly Associated with COVID-19 and Moxifloxacin Use. A Report of 2 Cases.
Topics: COVID-19; Glaucoma; Humans; Iris; Iris Diseases; Moxifloxacin; Syndrome; Transillumination | 2023 |